Aurélie Barrail‐Tran

1.0k total citations
35 papers, 639 citations indexed

About

Aurélie Barrail‐Tran is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Aurélie Barrail‐Tran has authored 35 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 18 papers in Virology and 10 papers in Emergency Medicine. Recurrent topics in Aurélie Barrail‐Tran's work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (18 papers) and HIV-related health complications and treatments (10 papers). Aurélie Barrail‐Tran is often cited by papers focused on HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (18 papers) and HIV-related health complications and treatments (10 papers). Aurélie Barrail‐Tran collaborates with scholars based in France, United Kingdom and United States. Aurélie Barrail‐Tran's co-authors include Anne‐Marie Taburet, Valérie Furlan, Caroline Barau, Olivier Lambotte, Roger Le Grand, Christine Bourgeois, Delphine Desjardins, France Mentré, Cécile Goujard and Claire Lagathu and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Aurélie Barrail‐Tran

33 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélie Barrail‐Tran France 16 387 194 117 112 83 35 639
Rubin Lubomirov Spain 13 374 1.0× 239 1.2× 64 0.5× 108 1.0× 128 1.5× 38 717
Robin DiFrancesco United States 18 538 1.4× 298 1.5× 117 1.0× 137 1.2× 204 2.5× 53 968
Odin Naderer United States 12 287 0.7× 109 0.6× 49 0.4× 217 1.9× 69 0.8× 32 729
Julie A. Predhomme United States 13 581 1.5× 272 1.4× 114 1.0× 227 2.0× 101 1.2× 17 749
Agnes I. Veldkamp Netherlands 17 697 1.8× 510 2.6× 118 1.0× 185 1.7× 140 1.7× 27 943
Monika Schöller‐Gyüre Belgium 14 518 1.3× 298 1.5× 87 0.7× 144 1.3× 122 1.5× 20 598
Lillian Ting Canada 15 537 1.4× 303 1.6× 290 2.5× 273 2.4× 114 1.4× 26 1.1k
Patricia Lizak United States 15 296 0.8× 144 0.7× 47 0.4× 118 1.1× 107 1.3× 23 637
Alieu Amara United Kingdom 17 379 1.0× 172 0.9× 54 0.5× 117 1.0× 94 1.1× 36 637
R. Chris Rathbun United States 15 424 1.1× 172 0.9× 101 0.9× 235 2.1× 89 1.1× 35 729

Countries citing papers authored by Aurélie Barrail‐Tran

Since Specialization
Citations

This map shows the geographic impact of Aurélie Barrail‐Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Barrail‐Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Barrail‐Tran more than expected).

Fields of papers citing papers by Aurélie Barrail‐Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Barrail‐Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Barrail‐Tran. The network helps show where Aurélie Barrail‐Tran may publish in the future.

Co-authorship network of co-authors of Aurélie Barrail‐Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Barrail‐Tran. A scholar is included among the top collaborators of Aurélie Barrail‐Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Barrail‐Tran. Aurélie Barrail‐Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Desjardins, Delphine, Asier Sáez‐Cirión, Aurélie Barrail‐Tran, et al.. (2022). Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques. Cells. 11(19). 3104–3104. 6 indexed citations
3.
Dereuddre‐Bosquet, Nathalie, Valérie Furlan, Roger Le Grand, et al.. (2022). Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates. Pharmaceutics. 14(11). 2282–2282. 1 indexed citations
4.
Noé, Gaëlle, et al.. (2019). UPLC–MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 181. 113057–113057. 23 indexed citations
5.
Barrail‐Tran, Aurélie, Corine Vincent, Valérie Furlan, et al.. (2015). Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir. Antimicrobial Agents and Chemotherapy. 59(12). 7903–7905. 2 indexed citations
6.
Cotte, Laurent, Aurélie Barrail‐Tran, Corine Vincent, et al.. (2014). Telaprevir Enhances Ribavirin-Induced Anaemia through Renal Function Impairment. Antiviral Therapy. 20(5). 479–486. 4 indexed citations
7.
Bhatt, Nilesh, Caroline Barau, Anjali Amin, et al.. (2014). Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment. Antimicrobial Agents and Chemotherapy. 58(6). 3182–3190. 30 indexed citations
8.
Lan, Nguyễn Thị Ngọc, Aurélie Barrail‐Tran, Nguyen Hong Duc, et al.. (2014). Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam. PLoS ONE. 9(1). e84866–e84866. 34 indexed citations
9.
Parienti, Jean‐Jacques, Aurélie Barrail‐Tran, Xavier Duval, et al.. (2013). Adherence Profiles and Therapeutic Responses of Treatment-Naive HIV-Infected Patients Starting Boosted Atazanavir-Based Therapy in the ANRS 134-COPHAR 3 Trial. Antimicrobial Agents and Chemotherapy. 57(5). 2265–2271. 27 indexed citations
10.
Barrail‐Tran, Aurélie, et al.. (2013). Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors. Clinical Pharmacokinetics. 52(10). 815–831. 120 indexed citations
11.
Giraud, Julie, et al.. (2012). Prise en charge thérapeutique des patients infectés par le VIH : synthèse des recommandations du rapport Yeni. Journal de Pharmacie Clinique. 31(2). 89–103. 1 indexed citations
12.
Rekić, Dinko, Daniel Röshammar, Martin Bergstrand, et al.. (2012). External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients. The AAPS Journal. 15(2). 308–315. 3 indexed citations
13.
Savić, Radojka M., Aurélie Barrail‐Tran, Xavier Duval, et al.. (2012). Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients. Clinical Pharmacology & Therapeutics. 92(5). 575–583. 40 indexed citations
14.
Goldwirt, Lauriane, Joséphine Braun, Nathalie De Castro, et al.. (2011). Switch from Enfuvirtide to Raltegravir Lowers Plasma Concentrations of Darunavir and Tipranavir: a Pharmacokinetic Substudy of the EASIER-ANRS 138 Trial. Antimicrobial Agents and Chemotherapy. 55(7). 3613–3615. 8 indexed citations
15.
Gallien, Sébastien, Constance Delaugerre, Isabelle Charreau, et al.. (2011). Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. AIDS. 25(5). 665–669. 27 indexed citations
16.
Barrail‐Tran, Aurélie, Anne‐Marie Taburet, & Jean‐Marie Poirier. (2011). Niveau de preuve du suivi thérapeutique pharmacologique de l’indinavir. Therapies. 66(3). 239–246.
17.
Barrail‐Tran, Aurélie, Anne‐Marie Taburet, & Jean‐Marie Poirier. (2011). Niveau de preuve du suivi thérapeutique pharmacologique du lopinavir. Therapies. 66(3). 231–238. 1 indexed citations
18.
Barau, Caroline, Aurélie Barrail‐Tran, Dalila Habès, et al.. (2011). Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients. Liver Transplantation. 17(10). 1152–1158. 12 indexed citations
19.
Goldwirt, Lauriane, et al.. (2009). Quantification of raltegravir (MK0518) in human plasma by high-performance liquid chromatography with photodiode array detection. Journal of Chromatography B. 878(3-4). 456–460. 11 indexed citations
20.
Barrail‐Tran, Aurélie, Laurence Morand‐Joubert, G Raguin, et al.. (2008). Predictive Values of the Human Immunodeficiency Virus Phenotype and Genotype and of Amprenavir and Lopinavir Inhibitory Quotients in Heavily Pretreated Patients on a Ritonavir-Boosted Dual-Protease-Inhibitor Regimen. Antimicrobial Agents and Chemotherapy. 52(5). 1642–1646. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rubin Lubomirov Breakdown of academic impact, for papers by Robin DiFrancesco Breakdown of academic impact, for papers by Odin Naderer Breakdown of academic impact, for papers by Julie A. Predhomme Breakdown of academic impact, for papers by Agnes I. Veldkamp Breakdown of academic impact, for papers by Monika Schöller‐Gyüre Breakdown of academic impact, for papers by Lillian Ting Breakdown of academic impact, for papers by Patricia Lizak Breakdown of academic impact, for papers by Alieu Amara Breakdown of academic impact, for papers by R. Chris Rathbun
Rankless by CCL
2026